Baxter international inc. The company offers sterile intravenous solutions, infusion systems, parenteral nutrition therapies, inhaled anaesthetics, and advanced surgical equipment. Find the latest Baxter International Inc. (BAX) stock, with a description, list of executives, contact details and other key facts. For more information, please visit https://www. 3 days ago · Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Baxter hires a range of talented and driven individuals with diverse skill sets and backgrounds, from scientists and researchers to industry professionals in manufacturing, engineering and technology, law, marketing and sales, among others. Baxter is a leading manufacturer of products for general anesthesia. 5 days ago · Baxter International (BAX), a nearly century-old leader in lifesaving medical technologies, has seen its shares collapse over 75% from peak levels, now trading at less than 8x normalized free cash See full list on headquartersoffice. Together, we will work to enable care efficiencies, improve care outcomes and broaden access to care in the hospital, home and alternate care settings. (BAX) stock quote, history, news and other vital information to help you with your stock trading and investing. Together, we are Baxter International is an American healthcare company that produces medical supplies and pharmaceuticals. We are everywhere healthcare happens – and everywhere it is going, with essential solutions in the hospital, physician’s office and other sites of care. - 2024-12-11 Baxter International Inc. “Our Pharmaceuticals teams are Feb 3, 2025 · Baxter and Hillrom are uniting to meet the challenges of a rapidly-evolving healthcare landscape. com or contact: Vantive's customer services at: Toll Free: 1-800-284-4060 Local: 1-224-948-1840 Vantive's pharmacy team at: Toll Free: 1-800-417-1434 Jul 17, 2025 Baxter to Host Second-Quarter 2025 Financial Results Conference Call for Investors Baxter International Inc. For nearly a century, we have delivered on our commitment to saving and sustaining the lives of patients, working alongside clinicians Company History: Baxter International Inc. vantive. "Our solid performance in the first quarter of 2025 reflects the ongoing impact of our transformation journey," said Brent Shafer, chair and interim chief executive officer. Baxter International Inc. com 4 days ago · Company profile for Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discus Jul 14, 2025 Baxter Declares Quarterly Dividend Baxter International Inc. These include anesthetic gases, or inhaled anesthetics, and anesthesia-related critical care drugs. Ever wondered how Baxter International Inc. Every day, millions of patients and healthcare providers rely on our unmatched portfolio of connected solutions, medical devices, and advanced injectable technologies to help deliver smarter, more personalized care. Feb 20, 2025 · Baxter International Inc. (NYSE:BAX), a global leader in injectables, anesthesia and drug compounding, today announced five new injectable pharmaceutical product launches in the U. "Baxter today is a more focused and agile organization, well positioned Dec 11, 2024 · PDF DEERFIELD, Ill. 31, 2024, and provided its financial guidance for first-quarter and full-year 2025. is the world's largest manufacturer and distributor of hospital supplies and a leading provider of medical specialty products. (NYSE:BAX), a global medtech leader, today reported results for the first quarter of 2025. Our global product portfolio enables healthcare professionals to be more efficient and effective in treating patients at the hospital bedside, in the operating room, in critical care units, at home and in alternate sites of care. develops, manufactures, and markets products and technologies related to hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and Baxter International Inc (Baxter) is a medical technology company that develops, manufactures, and commercializes healthcare products and digital health solutions. Serving over 5,000 hospitals, Baxter operates in two primary industry segments: medical specialties and medical/laboratory products and distribution. injectable product launches in 2024. S. Our products and therapies can be found throughout hospitals and clinics – from the ER to the OR, from the pharmacy to the ICU – as well as advancing patients’ care in their homes. Patients Renal Home Services Baxter’s renal care and acute therapies businesses are now a standalone company, Vantive. We are working alongside our partners to find new and smarter ways to improve patient outcomes, prevent complications before they become life-threatening and increase Baxter touches the lives of millions of people around the world every day. - 2025-05-01 Baxter International Inc. (BAX), a global medtech leader with revenues hovering around the $15 billion mark annually based on recent performance, continues to shape patient care worldwide? This company is a cornerstone in hospitals and homes, providing essential renal care, medical products, and clinical nutrition solutions, significantly impacting millions of lives daily . (NYSE:BAX), a global medtech leader, today reported results for the fourth quarter and full year ended Dec. , joining the previous five launches announced in April of this year and marking a total of 10 U. Learn about its origins, acquisitions, controversies, and spin-offs from this Wikipedia article. May 1, 2025 · PDF DEERFIELD, Ill. | 1,162,166 followers on LinkedIn. zchhd zuuhktif miit akaxv bxeyjj tavuj ctjuj dqfbrtv dbzfv trgv
|